HIV Type 1 infection among ethiopian immigrants to Israel: Enhanced in vitro antibody stimulation for estimating the length of the window period

AIDS Research and Human Retroviruses

Volumn 25, Issue 2, 2009, Pages 165-174

  Novikov, Ilya ^a   Jehuda Cohen, Tamar ^b  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

AFRICA; ANTIBODY PRODUCTION; ARTICLE; ASSAY; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMIGRANT; INCIDENCE; ISRAEL; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PREVALENCE; PRIORITY JOURNAL; REFUGEE; SEROCONVERSION; SEROPREVALENCE;

ANTIBODIES, VIRAL; EMIGRANTS AND IMMIGRANTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; ISRAEL; MALE; MODELS, THEORETICAL; PREVALENCE; TIME FACTORS;

EID: 60849085220     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0151     Document Type: Article

References (32)

1. Chun TW, Justement JS, Moir S, et al.: Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: Implications for eradication of virus. J Infect Dis 2007;195:1762-1764.
2. Litvak E, Siegel JE, Pauker SG, Lallemant M, Fineberg HV, and Weinstein MC: Whose blood is safer? The effect of the stage of the epidemic on screening for HIV. Med Decis Making 1997;17:455-463.
3. Shearer GM and Clerici M: Protective immunity against HIV infection: Has nature done the experiment for us? Immunol Today 1996;17:21-24.
4. CDC Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines 2006. HIV infection: Detection, counseling, and referral. Diagnostic testing. MMWR Recomm Rep 2006;55(RR-11):1-94.
5. Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, and Bollinger R: The AIDS epidemic in India: A new method for estimating current human immunodeficiency virus (HIV) incidence rates. Am J Epidemiol 1995;142:709-713.
6. Pilcher CD, Price MA, Hoffman IF, et al.: Frequent detection of acute primary HIV infection in men in Malawi. AIDS 2004;18:517-524.
7. Lindback S, Thorstensson R, Karlsson AC, et al.: Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 2000;14:2333-2339.
8. Busch MP, Kleinman SH, and Nemo GJ: Current and emerging infectious risks of blood transfusions. JAMA 2003;289:959-962.
9. Jehuda-Cohen T, Slade BA, Powell JD, et al.: Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals. Proc Natl Acad Sci USA 1990;87:3972-3976.
10. Villinger F, Powell JD, Jehuda-Cohen T, et al.: Detection of occult simian immunodeficiency virus SIVsmm infection in asymptomatic seronegative nonhuman primates and evidence for variation in SIV gag sequence between in-vivo-and in-vitro-propagated virus. J Virol 1991;65:1855-1862.
11. Jehuda-Cohen T, Powell JD, Villinger F, Mayne AE, Sell KW, and Ansari AA: Evidence for simian immunodeficiency virus-specific IgM and IgG response in peripheral blood mononuclear cells of serum enzyme-linked immunosorbent assay-negative nonhuman primates. J Acquir Immune Defic Syndr 1994;7:539-550.
12. Jehuda-Cohen T, Powell JD, Sell KW, Villinger F, Lockwood E, McClure HM, and Ahmed-Ansari A: Transmission of retroviral infection by transfusion of seronegative blood in nonhuman primates. J Infect Dis 1991;163(6):1223-1228.
13. Jehuda-Cohen T, Villinger F, Powell JD, McClure HM, Sell KW, and Ansari AA: Presence of SIV antibodies in the sera of infants born to SIV-seronegative monkeys. J Acquir Immune Defic Syndr 1991;4(2):204-205.
14. Heilman U: THE FALASH MURA'S FATE-Ethiopians wait to immigrate as Israel U.S. Jews plan their future. A 7-part special JTA report on Ethiopian immigration to Israel, 2006.
15. Kaplan EH, Kedem E, and Pollack S: HIV incidence in Ethiopian immigrants to Israel. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:465-469.
16. Busch MP, Lee LL, Satten GA, et al.: Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 1995;35:91-97.
17. Mumo J, Vansover A, and Jehuda-Cohen T: Adults versus student blood donor populations in Nairobi, Kenya: Variances in incidence versus prevalence of HIV infection. Submitted.
18. Pillonel J, Laperche S, Saura C, Desenclos JC, and Courouce AM: Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000. Transfusion 2002;42:980-988.
19. Alvarez do Barrio M, Gonzalez Diez R, Hernandez Sanchez JM, and Oyonarte Gomez S: Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing. Euro Surveill 2005;10:20-22.
20. Jehuda-Cohen T, Mumo JM, Bwayo JJ, and Pezzella M: Detection of HIV infection during window-period using polyclonal B-cell activation test. AIDS 1997;11:124-125.
21. Jehuda-Cohen T: The false-positive polymerase chain reaction and the ostrich. J Infect Dis 1995;172:1420-1421.
22. http://www.sfaf.org/aids101/hiv-testing.html#window.
23. Myers TM: A medical care program for Ethiopian Jewish migrants in Addis Ababa. Isr J Med Sci 1993,29:334-338.
24. Kaplan EH, Soskolne V, Adler B, Leventhal A, and Shtarkshall RA: A model-based evaluation of a cultural mediator outreach program for HIV+ Ethiopian immigrants in Israel. Eval Rev 2002;26:382-394.
25. Chemtob D and Grossman Z: Epidemiology of adult and adolescent HIV infection in Israel: A country of immigration. Int J STD AIDS 2004;15:691-696.
26. Pollack S: Epidemiological and immunological study of HIV-seropositive Ethiopian immigrants in Israel. The Israel AIDS Study Group. Isr J Med Sci 1993;29:19-23.
27. Culture tubes for the stimunology process. SMART BIOTECH LTD., 2 Bergman St., Rabin Science Park, Rehovot 76705, Israel.
28. van Gemen B, van Beuningen R, Nabbe A, et al.: A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J Virol Methods 1994;49:157-167.
29. Alkan ML, Maayan S, Belmaker I, Arbeli Y, Mani N, and Ben-Yshai F: Serological markers for hepatitis B and treponemal infection among HIV carriers from Ethiopia. Isr J Med Sci 1993;29:390-392.
30. Federal Ministry of Health/National HIV/AIDS Prevention and Control Office also Human Services Centers for Disease Control and Prevention Office in Ethiopia: AIDS in Ethiopia. In six report, 2006.
31. Israel Ministry of Immigrant Absorption: Immigration to Israel Summary Data 1989-2000. In The Ministry of Immigrant Absorption, 2001.
32. Fiebig EW, Heldebrant CM, Smith RI, et al.: Intermittent low-level viremia in very early primary HIV-1 infection. J Acquir Immune Defic Syndr 2005;39:133-137.